Journal article
An in vivo mouse model of total intravenous anesthesia during cancer resection surgery
JA Dubowitz, F Jost-Brinkmann, AI Ziegler, RD Gillis, B Riedel, EK Sloan
Journal of Visualized Experiments | MyJove Corp | Published : 2021
DOI: 10.3791/62747
Abstract
Anesthesia is a routine component of cancer care that is used for diagnostic and therapeutic procedures. The anesthetic technique has recently been implicated in impacting long-term cancer outcomes, possibly through modulation of adrenergic-inflammatory responses that impact cancer cell behavior and immune cell function. Emerging evidence suggests that propofol-based total intravenous anesthesia (TIVA) may be beneficial for long-term cancer outcomes when compared to inhaled volatile anesthesia. However, the available clinical findings are inconsistent. Preclinical studies that identify the underlying mechanisms involved are critically needed to guide the design of clinical studies that will ..
View full abstractRelated Projects (1)
Grants
Awarded by Clinical Trial Center, China Medical University Hospital
Funding Acknowledgements
The authors wish to thank members of the Cancer NeuralImmune Laboratory and Dr. Cameron Nowell at Monash Institute of Pharmaceutical Sciences, Monash University, Parkville. This work was supported by grants from National Health and Medical Research Council 1147498, the National Breast Cancer Foundation IIRS-20-025, the Australian and New Zealand College of Anaesthetists (ANZCA), Perpetual and CTC for Cancer Therapeutics.